Acceptability Lactoserum (Dermacyd Delicata - New Fragrance)

Safety Dermatological Evaluation of the Acceptability With Gynecological Follow up for Dermacyd Femina Delicata

Status

Completed

Phases

Phase 4

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00497783

Enrollment

Registered

2007-07-09

Start date

2007-05-31

Completion date

Unknown

Last updated

2008-05-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hygiene

Brief summary

The purpose of this study is to demonstrate the safety of the gynecological formulation in normal and usual usage condition of Dermacyd Femina Delicata.

Interventions

DRUGLactoserum

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

SUPPORTIVE_CARE

Masking

NONE

Eligibility

Sex/Gender

FEMALE

Age

18 Years to 60 Years

Healthy volunteers

Yes

Inclusion criteria

* Integral skin in the tested region

Exclusion criteria

* Pregnancy or breastfeeding women * Use of Anti-inflammatory or immune-suppression drugs * Topical medication use at the tested region * Active cutaneous gynaecological disease which may interfere in study results * Personal history of allergic disease at the area to be treated * Allergic or atopic history The above information is not intended to contain considerations relevant to a patient's potential participation in a clinical trial.

Design outcomes

Primary

Measure	Time frame
Clinical and local tolerability	21 days
Adverse events and their association with the treatment.	21 days

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026